Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine

statnews.com/2025/10/30/eli-lilly-zepbound-mounjaro-bestselling-obesity-drug

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially been surpassed by Eli Lilly.
Lilly’s tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, saw $10.1 billion in sales in the third…

This story appeared on statnews.com, 2025-10-31 01:02:01.914000.
The Entire Business World on a Single Page. Free to Use →